Press Release


LEH Pharma appoints two new members to its Scientific Advisory Board
Jun 13, 2018 19:00 JST
LEH Pharma Ltd, the leading provider of novel ocular implants for macular disorders today announces the appointment of Professor Robert Devenyi and Dr Sadeer Hannush to its Scientific Advisory Board (SAB).
More info..

LEH Pharma announces appointment of Chairman
May 03, 2018 14:00 JST
LEH Pharma Ltd, the leading provider of novel ocular implants for macular disorders, today announces the appointment of Sir Henry Riley as Chairman of the Board.
More info..

LEH PHARMA LTD.: Company Update
Apr 18, 2018 20:30 JST
LEH Pharma Ltd, a leading provider of revolutionary ocular implants for macular disorders, provides an update on progress following the commercial launch in November 2017 of its EyeMax lens, a unique, proven and patented product marketed internationally for the treatment of age-related macular degeneration (AMD). EyeMax is currently being implanted by c.100 surgeons in over 25 countries around the world, with the recent addition of Australia and Ecuador.
More info..

Latest Release


More Latest Release >>